Nursing 210 fluid and cells
This presentation is the property of its rightful owner.
Sponsored Links
1 / 37

Nursing 210 Fluid and Cells PowerPoint PPT Presentation


  • 71 Views
  • Uploaded on
  • Presentation posted in: General

Nursing management of patients with hematologic dysfunction. Nursing 210 Fluid and Cells. Laurie Brown RN, MSN, MPA-HA, CCRN. Development of Blood Cells. Hemoglobin and Hematacrit. Hb: Women: 12-16 Men: 13.5-18. Hct: Women: 38-47% Men: 40-54%. Complete Blood Count.

Download Presentation

Nursing 210 Fluid and Cells

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Nursing 210 fluid and cells

Nursing management of patients with hematologic dysfunction

Nursing 210

Fluid and Cells

Laurie Brown RN, MSN, MPA-HA, CCRN


Nursing 210 fluid and cells

Development of Blood Cells


Hemoglobin and hematacrit

Hemoglobin and Hematacrit

Hb: Women: 12-16

Men: 13.5-18

Hct: Women: 38-47%

Men: 40-54%


Complete blood count

Complete Blood Count

White Blood Cells (WBC) 5,000-10,000


Wbc differential

Neutrophil

Eosinophil

Basophil

Lymphocyte

Monocyte

50-70%

2-5%

0-2%

20-40%

4-8%

WBCDifferential


Nursing 210 fluid and cells

CBC

Platelet Count

150,000-400,000


Nursing 210 fluid and cells

Red Cells

  • Mean Corpuscular Hemoglobin (MCH)

  • Mean Corpuscular Volume (MCV)

  • Mean Corpuscular Hemoglobin Concentration (MCHC)


Clotting

Clotting

  • Extrinsic

  • Intrinsic


Nursing 210 fluid and cells

Heparin

PTT

Coumadin

PT or INR

Vitamin K

Protamine sulfate


Drugs impairing the hematologic system

Drugs Impairing the Hematologic System

  • Drugs causing bone marrow suppression

  • Drugs causing hemolysis

  • Drugs that disrupt platelet action

  • Drugs that disrupt clotting action


Anemias

ANEMIAS

  • “Can Not Make”

  • “Lost”

  • “Destroyed”


Anemias1

Iron Deficiency

Pernicious Anemia

Folic Acid Deficiency

Trauma

Chronic loss

Sickle Cell

Infectious Agents

Antibodies

Aplastic Anemia

G6PD Deficiency

ANEMIAS


Sickle cell anemia

Sickle Cell Anemia

  • Pain Control

  • Sickle cell crisis

  • Rational for orders

  • Nursing orders


Pernicious anemia

Pernicious Anemia

  • Vitamin B 12

  • Intrinsic Factor

  • Cells mutate and become large

  • Development of Neurological problems


Clotting problems

Clotting Problems

  • Thrombocytopenia

  • Hemophilia

  • Von Willebrand

  • Disseminated Intravascular Coagulation (DIC)


Nursing 210 fluid and cells

DIC

“Imbalance between the process of coagulation and anticoagulation”


Nursing 210 fluid and cells

Treatment


Heparin administration

Heparin Administration

  • Heparin loading dose

  • Initial Maintenance Infusion

  • Dosage calculation often by patients weight


Transfusion administration

Identification

Lab values

Drs order verify

Pt assessment

IV site assessment

Documentation

Verify with 2nd RN

Monitor VS

Remain with the patient

TransfusionAdministration


Nursing 210 fluid and cells

  • Automatic IV infuser pump

  • Flow rate calculation

  • Blood/Blood product w/tag

  • 150 cc NS

  • Blood Administration Set

  • Gloves


Blood bank

Blood Bank

  • Patient name and I.D. number

  • Unit number and ABO/Rh type on bag with blood bag compatibility tag & bag unit/type

  • Verify expiration date on blood bag


Autologous blood transfusions

Autologous Blood Transfusions

  • Preoperative autologous blood donation

  • Acute normovolemic hemodilution

  • Intraoperative autologous transfusion

  • Postoperative blood salvage


Characteristics of normal cells

Characteristics of Normal Cells

  • Limited Cell Division

  • Specific Morphology

  • Small Nuclear-Cytoplasmic Ratio

  • Perform Specific Differentiated Functions

  • Adhere tightly together…

  • Are nonmigratory

  • Grow in an orderly and well differentiated manner

  • Are contact inhibited


Characteristics of malignant cells

Characteristics of Malignant Cells

  • Demonstrate rapid or continuous cellular division.

  • Show anaplastic morphology

  • Have alargenuclear-cytoplasmic ratio

  • Lose some or all differentiated functions

  • Adhere loosely together

  • Are able to migrate

  • Grow by invasion

  • Are not contact-inhibited


Leukemia

Leukemia

  • AML - Acute Myelogenous

  • ALL - Acute Lymphocytic

  • CML - Chronic Myelogenous

  • CLL - Chronic Lymphocytic


Fab leukemia classification

FAB Leukemia Classification

  • French American British Classification

  • Historically distinguishing AML from ALL was a major clinical problem

  • Chemotherapy dependent on tissue type


Acute leukemia nccn guidelines

Acute Leukemia NCCN Guidelines

  • National Comprehensive Cancer Network (NCCN) has issued guidelines for treatment of many cancers including Leukemia as well as other hematological malignancies

    http://www.nccn.org/index.html


Bone marrow aspiration

Bone Marrow Aspiration

  • Bone marrow biopsy

  • Bone marrow aspiration


Lymphoma

Lymphoma

  • Hodgkin’s lymphoma

  • Non-Hodgkin’s lymphoma


Multiple myeloma

Multiple Myeloma

  • Gammopathy

  • “M” Protein

    • called a tumor marker


History of myeloma

History of Myeloma

  • Skeletal evidence of myeloma obtained from Egyptian mummies

  • First case described in 1844

  • 1845 Dr Henry Bence Jones detected heat properties of urinary light chains

  • 1929 Bone marrow aspiration

  • 1937 serum protein electrophoresis

  • 1960 Alkeran and prednisone- first treatment


What is multiple myeloma

What is Multiple Myeloma?

  • A cancer of the bone marrow

    • The location where cells are produced

  • The affected cells are plasma cells

  • Plasma cells produce antibodies (proteins that fight off infection)


To many harmful plasma cells

To Many Harmful Plasma Cells

  • Abnormal Plasma Cells are called Myeloma Cells and develop without warning

  • Myeloma cells collect in bones and cause “soft spots” where the cell is damaged


Effects of the blood

Normal cells are not being produced in the bone marrow

Bones are damaged

Bone demineralization (soft spots)

Effects of the blood


Symptomatic multiple myeloma

Symptomatic Multiple Myeloma

  • Calcium

  • Renal

  • Anemia

  • Bone


  • Login